Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frovatriptan for Medication Overuse Headache
NCT01044251Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Jan 2010
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of frovatriptan in medication overuse headache (MOH), sponsored by University of Calgary. Started Jan 2010; status: completed.
02
Drugs
frovatriptan
03
Conditions
medication overuse headache (MOH)
Beyond the preview
Go deeper on NCT01044251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01044251.